nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—muscle cancer	0.478	1	CbGaD
Mefenamic acid—AKR1C3—Doxorubicin—muscle cancer	0.266	0.643	CbGbCtD
Mefenamic acid—PTGS2—Etoposide—muscle cancer	0.0633	0.153	CbGbCtD
Mefenamic acid—PTGS1—Etoposide—muscle cancer	0.0534	0.129	CbGbCtD
Mefenamic acid—CYP2C8—Etoposide—muscle cancer	0.0308	0.0746	CbGbCtD
Mefenamic acid—AKR1C3—Podofilox—Etoposide—muscle cancer	0.00283	0.592	CbGdCrCtD
Mefenamic acid—AKR1C3—Vinblastine—Vincristine—muscle cancer	0.00195	0.408	CbGdCrCtD
Mefenamic acid—Acetylsalicylic acid—TP53—muscle cancer	0.00159	0.233	CrCbGaD
Mefenamic acid—AKR1C2—testis—muscle cancer	0.00146	0.138	CbGeAlD
Mefenamic acid—PTGS2—hindlimb—muscle cancer	0.00111	0.104	CbGeAlD
Mefenamic acid—PTGS2—appendage—muscle cancer	0.000948	0.0896	CbGeAlD
Mefenamic acid—Floctafenine—PTGS2—muscle cancer	0.000815	0.12	CrCbGaD
Mefenamic acid—AKR1C3—smooth muscle tissue—muscle cancer	0.000732	0.0691	CbGeAlD
Mefenamic acid—AKR1C3—cardiac atrium—muscle cancer	0.000631	0.0596	CbGeAlD
Mefenamic acid—AKR1C3—tendon—muscle cancer	0.00055	0.052	CbGeAlD
Mefenamic acid—AKR1C3—bone marrow—muscle cancer	0.000533	0.0503	CbGeAlD
Mefenamic acid—Lumiracoxib—PTGS2—muscle cancer	0.000525	0.0772	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—muscle cancer	0.000525	0.0772	CrCbGaD
Mefenamic acid—AKR1C3—vagina—muscle cancer	0.00051	0.0482	CbGeAlD
Mefenamic acid—Nepafenac—PTGS2—muscle cancer	0.000499	0.0734	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—muscle cancer	0.000468	0.0688	CrCbGaD
Mefenamic acid—AKR1C3—testis—muscle cancer	0.000455	0.043	CbGeAlD
Mefenamic acid—Salsalate—PTGS2—muscle cancer	0.000415	0.061	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—muscle cancer	0.000409	0.0601	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—muscle cancer	0.000343	0.0504	CrCbGaD
Mefenamic acid—Melaena—Doxorubicin—muscle cancer	0.00032	0.0037	CcSEcCtD
Mefenamic acid—Cystitis—Doxorubicin—muscle cancer	0.000316	0.00366	CcSEcCtD
Mefenamic acid—PTGS2—embryo—muscle cancer	0.000315	0.0297	CbGeAlD
Mefenamic acid—Anaemia—Vincristine—muscle cancer	0.000315	0.00365	CcSEcCtD
Mefenamic acid—Colitis—Doxorubicin—muscle cancer	0.000314	0.00364	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Etoposide—muscle cancer	0.000313	0.00363	CcSEcCtD
Mefenamic acid—Polyuria—Methotrexate—muscle cancer	0.000312	0.00362	CcSEcCtD
Mefenamic acid—Photosensitivity—Methotrexate—muscle cancer	0.000312	0.00362	CcSEcCtD
Mefenamic acid—Oedema—Dactinomycin—muscle cancer	0.000311	0.0036	CcSEcCtD
Mefenamic acid—Fluid retention—Doxorubicin—muscle cancer	0.000311	0.0036	CcSEcCtD
Mefenamic acid—Urethral disorder—Etoposide—muscle cancer	0.000311	0.0036	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS2—muscle cancer	0.00031	0.0456	CrCbGaD
Mefenamic acid—Infection—Dactinomycin—muscle cancer	0.000309	0.00358	CcSEcCtD
Mefenamic acid—CYP2C8—renal system—muscle cancer	0.000307	0.029	CbGeAlD
Mefenamic acid—Aplastic anaemia—Doxorubicin—muscle cancer	0.000307	0.00356	CcSEcCtD
Mefenamic acid—Vertigo—Vincristine—muscle cancer	0.000306	0.00355	CcSEcCtD
Mefenamic acid—Hepatic failure—Methotrexate—muscle cancer	0.000305	0.00354	CcSEcCtD
Mefenamic acid—Leukopenia—Vincristine—muscle cancer	0.000305	0.00353	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Dactinomycin—muscle cancer	0.000304	0.00353	CcSEcCtD
Mefenamic acid—Erythema multiforme—Etoposide—muscle cancer	0.0003	0.00347	CcSEcCtD
Mefenamic acid—Coma—Doxorubicin—muscle cancer	0.000299	0.00347	CcSEcCtD
Mefenamic acid—Oesophagitis—Doxorubicin—muscle cancer	0.000299	0.00347	CcSEcCtD
Mefenamic acid—Anorexia—Dactinomycin—muscle cancer	0.000296	0.00344	CcSEcCtD
Mefenamic acid—Bladder pain—Doxorubicin—muscle cancer	0.000296	0.00343	CcSEcCtD
Mefenamic acid—Ecchymosis—Doxorubicin—muscle cancer	0.000296	0.00343	CcSEcCtD
Mefenamic acid—Convulsion—Vincristine—muscle cancer	0.000295	0.00342	CcSEcCtD
Mefenamic acid—Hypertension—Vincristine—muscle cancer	0.000294	0.00341	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000291	0.00337	CcSEcCtD
Mefenamic acid—Sepsis—Doxorubicin—muscle cancer	0.000284	0.00329	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000283	0.00329	CcSEcCtD
Mefenamic acid—Alopecia—Etoposide—muscle cancer	0.00028	0.00324	CcSEcCtD
Mefenamic acid—Lymphadenopathy—Doxorubicin—muscle cancer	0.000278	0.00323	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Vincristine—muscle cancer	0.000278	0.00322	CcSEcCtD
Mefenamic acid—Oedema—Vincristine—muscle cancer	0.000278	0.00322	CcSEcCtD
Mefenamic acid—Infection—Vincristine—muscle cancer	0.000276	0.0032	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Vincristine—muscle cancer	0.000272	0.00315	CcSEcCtD
Mefenamic acid—Photosensitivity—Doxorubicin—muscle cancer	0.000271	0.00314	CcSEcCtD
Mefenamic acid—Decreased appetite—Dactinomycin—muscle cancer	0.00027	0.00313	CcSEcCtD
Mefenamic acid—Vascular purpura—Doxorubicin—muscle cancer	0.000266	0.00308	CcSEcCtD
Mefenamic acid—Anorexia—Vincristine—muscle cancer	0.000265	0.00307	CcSEcCtD
Mefenamic acid—Hepatic failure—Doxorubicin—muscle cancer	0.000264	0.00306	CcSEcCtD
Mefenamic acid—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000262	0.00304	CcSEcCtD
Mefenamic acid—Hypotension—Vincristine—muscle cancer	0.00026	0.00301	CcSEcCtD
Mefenamic acid—PTGS1—smooth muscle tissue—muscle cancer	0.000259	0.0245	CbGeAlD
Mefenamic acid—Feeling abnormal—Dactinomycin—muscle cancer	0.000256	0.00297	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Etoposide—muscle cancer	0.000256	0.00297	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—muscle cancer	0.000255	0.0375	CrCbGaD
Mefenamic acid—Anaemia—Etoposide—muscle cancer	0.000255	0.00295	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000254	0.00295	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Methotrexate—muscle cancer	0.000253	0.00294	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000252	0.00292	CcSEcCtD
Mefenamic acid—Insomnia—Vincristine—muscle cancer	0.000251	0.00291	CcSEcCtD
Mefenamic acid—Renal impairment—Doxorubicin—muscle cancer	0.00025	0.00289	CcSEcCtD
Mefenamic acid—Paraesthesia—Vincristine—muscle cancer	0.000249	0.00289	CcSEcCtD
Mefenamic acid—PTGS1—renal system—muscle cancer	0.000249	0.0235	CbGeAlD
Mefenamic acid—Malaise—Etoposide—muscle cancer	0.000249	0.00288	CcSEcCtD
Mefenamic acid—Vertigo—Etoposide—muscle cancer	0.000248	0.00287	CcSEcCtD
Mefenamic acid—PTGS2—smooth muscle tissue—muscle cancer	0.000248	0.0234	CbGeAlD
Mefenamic acid—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000247	0.00286	CcSEcCtD
Mefenamic acid—Leukopenia—Etoposide—muscle cancer	0.000247	0.00286	CcSEcCtD
Mefenamic acid—Purpura—Doxorubicin—muscle cancer	0.000246	0.00286	CcSEcCtD
Mefenamic acid—Body temperature increased—Dactinomycin—muscle cancer	0.000246	0.00285	CcSEcCtD
Mefenamic acid—Abdominal pain—Dactinomycin—muscle cancer	0.000246	0.00285	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000245	0.00284	CcSEcCtD
Mefenamic acid—Loss of consciousness—Etoposide—muscle cancer	0.000242	0.00281	CcSEcCtD
Mefenamic acid—Decreased appetite—Vincristine—muscle cancer	0.000242	0.0028	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Vincristine—muscle cancer	0.00024	0.00278	CcSEcCtD
Mefenamic acid—Convulsion—Etoposide—muscle cancer	0.000239	0.00277	CcSEcCtD
Mefenamic acid—Hyponatraemia—Doxorubicin—muscle cancer	0.000238	0.00276	CcSEcCtD
Mefenamic acid—PTGS2—renal system—muscle cancer	0.000238	0.0225	CbGeAlD
Mefenamic acid—Hypertension—Etoposide—muscle cancer	0.000238	0.00276	CcSEcCtD
Mefenamic acid—Constipation—Vincristine—muscle cancer	0.000238	0.00275	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000238	0.00275	CcSEcCtD
Mefenamic acid—Asthma—Methotrexate—muscle cancer	0.000237	0.00275	CcSEcCtD
Mefenamic acid—Eosinophilia—Methotrexate—muscle cancer	0.000235	0.00272	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000233	0.0027	CcSEcCtD
Mefenamic acid—Pancreatitis—Methotrexate—muscle cancer	0.000232	0.00269	CcSEcCtD
Mefenamic acid—Discomfort—Etoposide—muscle cancer	0.000232	0.00269	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—muscle cancer	0.000229	0.0336	CrCbGaD
Mefenamic acid—Gastrointestinal pain—Vincristine—muscle cancer	0.000227	0.00263	CcSEcCtD
Mefenamic acid—Confusional state—Etoposide—muscle cancer	0.000227	0.00263	CcSEcCtD
Mefenamic acid—Pancytopenia—Methotrexate—muscle cancer	0.000225	0.00261	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Etoposide—muscle cancer	0.000225	0.00261	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—muscle cancer	0.000224	0.0329	CrCbGaD
Mefenamic acid—Infection—Etoposide—muscle cancer	0.000224	0.00259	CcSEcCtD
Mefenamic acid—PTGS1—cardiac atrium—muscle cancer	0.000223	0.0211	CbGeAlD
Mefenamic acid—Asthenia—Dactinomycin—muscle cancer	0.000223	0.00259	CcSEcCtD
Mefenamic acid—CYP2C8—vagina—muscle cancer	0.000223	0.021	CbGeAlD
Mefenamic acid—Dysuria—Methotrexate—muscle cancer	0.000222	0.00257	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Etoposide—muscle cancer	0.00022	0.00255	CcSEcCtD
Mefenamic acid—Tachycardia—Etoposide—muscle cancer	0.00022	0.00255	CcSEcCtD
Mefenamic acid—Body temperature increased—Vincristine—muscle cancer	0.00022	0.00255	CcSEcCtD
Mefenamic acid—Abdominal pain—Vincristine—muscle cancer	0.00022	0.00255	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Doxorubicin—muscle cancer	0.000219	0.00254	CcSEcCtD
Mefenamic acid—Skin disorder—Etoposide—muscle cancer	0.000219	0.00253	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Methotrexate—muscle cancer	0.000216	0.00251	CcSEcCtD
Mefenamic acid—Anorexia—Etoposide—muscle cancer	0.000215	0.00249	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000214	0.00248	CcSEcCtD
Mefenamic acid—Diarrhoea—Dactinomycin—muscle cancer	0.000213	0.00247	CcSEcCtD
Mefenamic acid—Pneumonia—Methotrexate—muscle cancer	0.000213	0.00246	CcSEcCtD
Mefenamic acid—Drowsiness—Methotrexate—muscle cancer	0.000211	0.00245	CcSEcCtD
Mefenamic acid—Hypotension—Etoposide—muscle cancer	0.00021	0.00244	CcSEcCtD
Mefenamic acid—Gastritis—Doxorubicin—muscle cancer	0.00021	0.00244	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00021	0.00243	CcSEcCtD
Mefenamic acid—Renal failure—Methotrexate—muscle cancer	0.000208	0.00241	CcSEcCtD
Mefenamic acid—Stomatitis—Methotrexate—muscle cancer	0.000206	0.00239	CcSEcCtD
Mefenamic acid—Conjunctivitis—Methotrexate—muscle cancer	0.000205	0.00238	CcSEcCtD
Mefenamic acid—Asthma—Doxorubicin—muscle cancer	0.000205	0.00238	CcSEcCtD
Mefenamic acid—Eosinophilia—Doxorubicin—muscle cancer	0.000203	0.00236	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—muscle cancer	0.000202	0.0298	CrCbGaD
Mefenamic acid—Paraesthesia—Etoposide—muscle cancer	0.000202	0.00234	CcSEcCtD
Mefenamic acid—Haematuria—Methotrexate—muscle cancer	0.000202	0.00234	CcSEcCtD
Mefenamic acid—Pancreatitis—Doxorubicin—muscle cancer	0.000201	0.00233	CcSEcCtD
Mefenamic acid—Dyspnoea—Etoposide—muscle cancer	0.000201	0.00233	CcSEcCtD
Mefenamic acid—Somnolence—Etoposide—muscle cancer	0.0002	0.00232	CcSEcCtD
Mefenamic acid—Asthenia—Vincristine—muscle cancer	0.000199	0.00231	CcSEcCtD
Mefenamic acid—CYP2C8—testis—muscle cancer	0.000199	0.0188	CbGeAlD
Mefenamic acid—Vomiting—Dactinomycin—muscle cancer	0.000198	0.00229	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—muscle cancer	0.000197	0.00229	CcSEcCtD
Mefenamic acid—Rash—Dactinomycin—muscle cancer	0.000196	0.00227	CcSEcCtD
Mefenamic acid—Decreased appetite—Etoposide—muscle cancer	0.000196	0.00227	CcSEcCtD
Mefenamic acid—Pancytopenia—Doxorubicin—muscle cancer	0.000195	0.00226	CcSEcCtD
Mefenamic acid—PTGS1—tendon—muscle cancer	0.000195	0.0184	CbGeAlD
Mefenamic acid—Gastrointestinal disorder—Etoposide—muscle cancer	0.000194	0.00225	CcSEcCtD
Mefenamic acid—Constipation—Etoposide—muscle cancer	0.000192	0.00223	CcSEcCtD
Mefenamic acid—Dysuria—Doxorubicin—muscle cancer	0.000192	0.00223	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—muscle cancer	0.000191	0.00221	CcSEcCtD
Mefenamic acid—Diarrhoea—Vincristine—muscle cancer	0.00019	0.0022	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—muscle cancer	0.00019	0.0022	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—muscle cancer	0.00019	0.0022	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Methotrexate—muscle cancer	0.000187	0.00217	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000187	0.00217	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—muscle cancer	0.000186	0.00216	CcSEcCtD
Mefenamic acid—PTGS2—tendon—muscle cancer	0.000186	0.0176	CbGeAlD
Mefenamic acid—Feeling abnormal—Etoposide—muscle cancer	0.000185	0.00215	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Doxorubicin—muscle cancer	0.000185	0.00215	CcSEcCtD
Mefenamic acid—Nausea—Dactinomycin—muscle cancer	0.000185	0.00214	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—muscle cancer	0.000184	0.00213	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Etoposide—muscle cancer	0.000184	0.00213	CcSEcCtD
Mefenamic acid—Dizziness—Vincristine—muscle cancer	0.000184	0.00213	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—muscle cancer	0.000183	0.00212	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000181	0.0021	CcSEcCtD
Mefenamic acid—PTGS1—vagina—muscle cancer	0.000181	0.0171	CbGeAlD
Mefenamic acid—PTGS2—bone marrow—muscle cancer	0.00018	0.017	CbGeAlD
Mefenamic acid—Renal failure—Doxorubicin—muscle cancer	0.00018	0.00209	CcSEcCtD
Mefenamic acid—Erythema multiforme—Methotrexate—muscle cancer	0.000179	0.00208	CcSEcCtD
Mefenamic acid—Urticaria—Etoposide—muscle cancer	0.000179	0.00207	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—muscle cancer	0.000178	0.00207	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—muscle cancer	0.000178	0.00207	CcSEcCtD
Mefenamic acid—Abdominal pain—Etoposide—muscle cancer	0.000178	0.00206	CcSEcCtD
Mefenamic acid—Body temperature increased—Etoposide—muscle cancer	0.000178	0.00206	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—muscle cancer	0.000178	0.00206	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—muscle cancer	0.000177	0.00205	CcSEcCtD
Mefenamic acid—Vomiting—Vincristine—muscle cancer	0.000177	0.00205	CcSEcCtD
Mefenamic acid—Rash—Vincristine—muscle cancer	0.000175	0.00203	CcSEcCtD
Mefenamic acid—Dermatitis—Vincristine—muscle cancer	0.000175	0.00203	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—muscle cancer	0.000175	0.00202	CcSEcCtD
Mefenamic acid—Headache—Vincristine—muscle cancer	0.000174	0.00202	CcSEcCtD
Mefenamic acid—PTGS2—vagina—muscle cancer	0.000173	0.0163	CbGeAlD
Mefenamic acid—Agranulocytosis—Doxorubicin—muscle cancer	0.000171	0.00198	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—muscle cancer	0.000168	0.00194	CcSEcCtD
Mefenamic acid—PTGS1—head—muscle cancer	0.000167	0.0158	CbGeAlD
Mefenamic acid—Mental disorder—Methotrexate—muscle cancer	0.000166	0.00193	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—muscle cancer	0.000165	0.00191	CcSEcCtD
Mefenamic acid—Nausea—Vincristine—muscle cancer	0.000165	0.00191	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—muscle cancer	0.000164	0.0019	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—muscle cancer	0.000164	0.0019	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—muscle cancer	0.000162	0.00188	CcSEcCtD
Mefenamic acid—Asthenia—Etoposide—muscle cancer	0.000161	0.00187	CcSEcCtD
Mefenamic acid—PTGS1—testis—muscle cancer	0.000161	0.0152	CbGeAlD
Mefenamic acid—Urethral disorder—Doxorubicin—muscle cancer	0.000161	0.00187	CcSEcCtD
Mefenamic acid—PTGS2—head—muscle cancer	0.000159	0.0151	CbGeAlD
Mefenamic acid—Pruritus—Etoposide—muscle cancer	0.000159	0.00185	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—muscle cancer	0.000156	0.0018	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—muscle cancer	0.000155	0.0018	CcSEcCtD
Mefenamic acid—Diarrhoea—Etoposide—muscle cancer	0.000154	0.00179	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—muscle cancer	0.000153	0.00178	CcSEcCtD
Mefenamic acid—Tinnitus—Doxorubicin—muscle cancer	0.000153	0.00178	CcSEcCtD
Mefenamic acid—Anaemia—Methotrexate—muscle cancer	0.000153	0.00177	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—muscle cancer	0.000149	0.00173	CcSEcCtD
Mefenamic acid—Dizziness—Etoposide—muscle cancer	0.000149	0.00173	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—muscle cancer	0.000148	0.00172	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—muscle cancer	0.000148	0.00171	CcSEcCtD
Mefenamic acid—Arrhythmia—Doxorubicin—muscle cancer	0.000147	0.0017	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—muscle cancer	0.000145	0.00168	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—muscle cancer	0.000144	0.00167	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—muscle cancer	0.000143	0.00166	CcSEcCtD
Mefenamic acid—Vomiting—Etoposide—muscle cancer	0.000143	0.00166	CcSEcCtD
Mefenamic acid—Rash—Etoposide—muscle cancer	0.000142	0.00164	CcSEcCtD
Mefenamic acid—Dermatitis—Etoposide—muscle cancer	0.000142	0.00164	CcSEcCtD
Mefenamic acid—Headache—Etoposide—muscle cancer	0.000141	0.00163	CcSEcCtD
Mefenamic acid—Flatulence—Doxorubicin—muscle cancer	0.000141	0.00163	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—muscle cancer	0.00014	0.00163	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00014	0.00162	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—muscle cancer	0.000139	0.00161	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—muscle cancer	0.000139	0.00161	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—muscle cancer	0.000136	0.00158	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—muscle cancer	0.000135	0.00156	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—muscle cancer	0.000135	0.00156	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—muscle cancer	0.000134	0.00155	CcSEcCtD
Mefenamic acid—Nausea—Etoposide—muscle cancer	0.000134	0.00155	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—muscle cancer	0.000133	0.00154	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—muscle cancer	0.000132	0.00153	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—muscle cancer	0.000132	0.00153	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—muscle cancer	0.000131	0.00152	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—muscle cancer	0.000129	0.0015	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—muscle cancer	0.000129	0.00149	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—muscle cancer	0.000129	0.00149	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—muscle cancer	0.000128	0.00149	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—muscle cancer	0.000128	0.00148	CcSEcCtD
Mefenamic acid—Palpitations—Doxorubicin—muscle cancer	0.000126	0.00147	CcSEcCtD
Mefenamic acid—Hypotension—Methotrexate—muscle cancer	0.000126	0.00146	CcSEcCtD
Mefenamic acid—Loss of consciousness—Doxorubicin—muscle cancer	0.000126	0.00146	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—muscle cancer	0.000124	0.00144	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—muscle cancer	0.000123	0.00143	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—muscle cancer	0.000122	0.00141	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—muscle cancer	0.000121	0.00141	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—muscle cancer	0.000121	0.0014	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000121	0.0014	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—muscle cancer	0.00012	0.00139	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—muscle cancer	0.00012	0.00139	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—muscle cancer	0.00012	0.00139	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—muscle cancer	0.000119	0.00138	CcSEcCtD
Mefenamic acid—Dyspepsia—Methotrexate—muscle cancer	0.000119	0.00138	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—muscle cancer	0.000118	0.00136	CcSEcCtD
Mefenamic acid—Decreased appetite—Methotrexate—muscle cancer	0.000117	0.00136	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—muscle cancer	0.000117	0.00135	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—muscle cancer	0.000117	0.00135	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000116	0.00135	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—muscle cancer	0.000116	0.00134	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—muscle cancer	0.000115	0.00133	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—muscle cancer	0.000114	0.00132	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—muscle cancer	0.000114	0.00132	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—muscle cancer	0.000113	0.00131	CcSEcCtD
Mefenamic acid—Anorexia—Doxorubicin—muscle cancer	0.000111	0.00129	CcSEcCtD
Mefenamic acid—Feeling abnormal—Methotrexate—muscle cancer	0.000111	0.00129	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—muscle cancer	0.00011	0.00128	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—muscle cancer	0.000109	0.00126	CcSEcCtD
Mefenamic acid—Urticaria—Methotrexate—muscle cancer	0.000107	0.00124	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—muscle cancer	0.000107	0.00124	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—muscle cancer	0.000107	0.00124	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—muscle cancer	0.000106	0.00122	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—muscle cancer	0.000105	0.00122	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—muscle cancer	0.000104	0.00121	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—muscle cancer	0.000104	0.0012	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—muscle cancer	0.000103	0.00119	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—muscle cancer	0.000101	0.00118	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000101	0.00117	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—muscle cancer	9.98e-05	0.00116	CcSEcCtD
Mefenamic acid—Asthenia—Methotrexate—muscle cancer	9.67e-05	0.00112	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—muscle cancer	9.62e-05	0.00112	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—muscle cancer	9.55e-05	0.00111	CcSEcCtD
Mefenamic acid—Pruritus—Methotrexate—muscle cancer	9.54e-05	0.00111	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—muscle cancer	9.27e-05	0.00107	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—muscle cancer	9.23e-05	0.00107	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—muscle cancer	9.23e-05	0.00107	CcSEcCtD
Mefenamic acid—Diarrhoea—Methotrexate—muscle cancer	9.22e-05	0.00107	CcSEcCtD
Mefenamic acid—Dizziness—Methotrexate—muscle cancer	8.92e-05	0.00103	CcSEcCtD
Mefenamic acid—Vomiting—Methotrexate—muscle cancer	8.57e-05	0.000994	CcSEcCtD
Mefenamic acid—Rash—Methotrexate—muscle cancer	8.5e-05	0.000985	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—muscle cancer	8.49e-05	0.000984	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—muscle cancer	8.45e-05	0.000979	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—muscle cancer	8.38e-05	0.000971	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—muscle cancer	8.26e-05	0.000957	CcSEcCtD
Mefenamic acid—Nausea—Methotrexate—muscle cancer	8.01e-05	0.000928	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—muscle cancer	7.99e-05	0.000926	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—muscle cancer	7.72e-05	0.000895	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—muscle cancer	7.42e-05	0.00086	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—muscle cancer	7.36e-05	0.000853	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—muscle cancer	7.35e-05	0.000852	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—muscle cancer	7.31e-05	0.000848	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—muscle cancer	6.93e-05	0.000804	CcSEcCtD
